Lapatinib Active Not Recruiting Phase 2 Trials for HER2-Positive Early Stage Breast Cancer Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01827163Paclitaxel With Trastuzumab and Lapatinib in HER2-Positive Early Stage Breast Cancer